INS and type 2 diabetes mellitus: The research did not show obvious therapeutic potential for GIP in T2DM, as it seems to have a minor effect on insulin secretion in those patients; it increases glucagon secretion and does not show glucose-lowering properties even at supra-physiological doses [8].